m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
What is happening with Tata Sons’ IPO?

Table of content

What is happening with Tata Sons’ IPO? 

There has been a lot of talk about Tata Sons’ impending IPO over the past couple of years. This is mainly because the Reserve Bank of India re-classified the Tata Group holding company as an upper layer NBFC (NBFC-UL) in September 2002.  This meant the Tata Sons would have to go for an IPO within 3 years of being classified as NBFC-UL.

There have been many news reports over the past couple of years on the possibility of Tata Sons listing, and if the Reserve Bank of India has allowed it an exemption from listing. According to a news report, in an RTI response, RBI has said that Tata Sons had never applied for such an exemption. 

But news reports suggest that Tata Sons has applied to surrender its registration as an NBFC-UL entity. It was already a ‘Core Investment Company’ under RBI’s regulations. This status of the Tata Group holding company as a core investment company is what precipitated RBI’s decision to classify it as a NBFC-UL.

Unless it secures this reclassification out of a core investment company, and RBI grants this request by Tata Sons, Tata Sons will have to list by September 2025.

Which companies does Tata Sons hold shares in? 

Tata Sons holds stakes in many listed companies, including Tata Consultancy Services (TCS), Tata Motors, Tata Consumer Products, Tata Chemicals, Tata Steel, among other Tata Group companies. Some companies like Tata Chemicals and Tata Investment Corporation also hold stakes in Tata Sons. These crossholdings are what pushed their stock prices higher, as investors pondered over the benefit these companies would earn if their parent firm listed on the stock markets.

Tata Sons also holds stakes in unlisted Tata Group companies like Tata Capital, Tata Advanced Systems, Tata Digital, Air India, Vistara, among other businesses.

According to news reports, Tata Sons posted a profit before exceptional items and taxes of ₹41,116.51 crore in FY24 on revenues of ₹43,893 crore. 

Will Tata Sons really list on the exchanges? 

As the nudge towards listing on the exchanges came due to a regulatory move by the RBI, only the banking regulator can now stop Tata Sons’ public listing. A large shareholder in Shapoorji-Pallonji Group (SP Group), which holds over 18% stake in Tata Sons, according to reports, has been pushing for a listing. This would have helped the to deleverage and reduce its large debt burden.

For now, investors looking forward to Tata Sons’ listing will have to wait and watch what other moves the Tata Group holding company and RBI make. This will seemingly continue till September 2025. Unless there is another twist in the tale.

More Related Articles

LCC Projects IPO: Issue Date, Lot Size, Price, Everything You Need to Know

LCC Projects IPO: Issue Date, Lot Size, Price, Everything You Need to Know

date-icon1 January 2026 | 10 mins read

LCC Projects Limited, an infrastructure and EPC company focused on road, bridge, and irrigation projects, is preparing for its public market debut with a main-board IPO on the Indian stock exchanges. The company executes construction contracts for government and semi-government agencies, riding on India’s sustained infrastructure push under national highway, rural connectivity and irrigation programmes. Over the last few years, LCC Projects has scaled its order book and revenue base meaningfully, supported by an expanding project portfolio across multiple states. 

Read More
Veeda Clinical Research IPO: Issue Date, Lot, Price, Everything You Need to Know

Veeda Clinical Research IPO: Issue Date, Lot, Price, Everything You Need to Know

date-icon1 January 2026 | 11 mins read

Veeda Clinical Research, a leading Indian contract research organisation (CRO), is preparing for its stock market debut after refiling its Draft Red Herring Prospectus (DRHP) with SEBI in early 2025. A CRO firm conducts outsourced research like clinical trials for pharma, biotech, and medical device companies on behalf of a sponsor. Founded in 2004 and headquartered in Ahmedabad, the company provides end-to-end clinical research services across bioavailability/bioequivalence (BA/BE), clinical pharmacology, early- and late-phase trials, bioanalytics, and specialty services to global pharma and biotech clients. Veeda operates through its main CRO platform and key subsidiaries such as Bioneeds India, strengthening its capabilities across pre-clinical and clinical segments in India’s fast-growing outsourcing market.

Read More
Waterways Leisure Tourism IPO: Issue Date, Lot Size, Price, Everything You Need to Know

Waterways Leisure Tourism IPO: Issue Date, Lot Size, Price, Everything You Need to Know

date-icon1 January 2026 | 7 mins read

Waterways Leisure Tourism, operating as Cordelia Cruises (India's only domestic ocean cruise line) is gearing up for its main-board IPO after SEBI approval in September 2025. Founded to tap the growing leisure travel market, the company runs cruises primarily from Mumbai and Chennai to destinations like Goa, Kochi, Lakshadweep, Visakhapatnam, Puducherry, and international ports in Sri Lanka, Thailand, Malaysia, and Singapore. With a focus on premium onboard experiences, Cordelia Cruises has captured significant mindshare among middle-class families and young travellers seeking affordable luxury vacations at sea.

Read More
View All